Allogene Therapeutics (ALLO)
(Real Time Quote from BATS)
$2.80 USD
-0.03 (-1.06%)
Updated Jul 22, 2024 11:06 AM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.38 |
Last EPS Surprise | 0.00% |
ABR | 1.61 |
Earnings ESP
|
9.43% |
---|---|
Current Year | -1.50 |
Next Year | -1.58 |
EPS (TTM) | -1.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.03M | 0.04M | 2.00M | 0.14M |
# of Estimates | 5 | 4 | 8 | 5 |
High Estimate | 15.00M | 0.05M | 15.00M | 0.20M |
Low Estimate | 0.03M | 0.03M | 0.10M | 0.10M |
Year ago Sales | 0.04M | 0.04M | 0.16M | 2.00M |
Year over Year Growth Est. | 7,480.00% | 0.00% | 1,151.33% | -92.81% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.36 | -1.50 | -1.58 |
# of Estimates | 12 | 11 | 12 | 12 |
Most Recent Consensus | -0.38 | -0.39 | -1.58 | -1.70 |
High Estimate | -0.28 | -0.32 | -1.33 | -1.21 |
Low Estimate | -0.39 | -0.41 | -1.70 | -2.02 |
Year ago EPS | -0.53 | -0.37 | -2.01 | -1.50 |
Year over Year Growth Est. | 33.96% | 2.70% | 25.37% | -5.95% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.36 | -1.50 | -1.58 |
7 Days Ago | -0.35 | -0.36 | -1.50 | -1.58 |
30 Days Ago | -0.35 | -0.36 | -1.50 | -1.60 |
60 Days Ago | -0.36 | -0.37 | -1.56 | -1.63 |
90 Days Ago | -0.38 | -0.38 | -1.65 | -1.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.32 | -1.33 | -1.34 |
Zacks Consensus Estimate | -0.35 | -0.36 | -1.50 | -1.58 |
Earnings ESP | 9.43% | 10.89% | 11.04% | 15.42% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.43 | -0.37 | -0.53 | NA |
Estimate | -0.38 | -0.47 | -0.53 | -0.59 | NA |
Difference | 0.00 | 0.04 | 0.16 | 0.06 | 0.07 |
Surprise | 0.00% | 8.51% | 30.19% | 10.17% | 12.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more